References
Nakura N, Hirakawa K, Takayanagi S, Mihara M (2023) Denosumab prevented periprosthetic bone resorption better than risedronate after total hip arthroplasty. J Bone Miner Metab. https://doi.org/10.1007/s00774-023-01405-2
Chiba D, Yamada N, Mori Y, Oyama M, Ohtsu S, Kuwahara Y, Baba K, Tanaka H, Aizawa T, Hanada S, Itoi E (2021) Mid-term results of a new femoral prosthesis using Ti-Nb-Sn alloy with low Young’s modulus. BMC Musculoskelet Disord 22:987. https://doi.org/10.1186/s12891-021-04879-1
Savio D, Bagno A (2022) When the total hip replacement fails: a review on the stress-shielding effect. Processes. https://doi.org/10.3390/pr10030612
D’Ambrosi R, Toni A, Czubak J, Guadilla J, Lieber L, Mariani I, Ursino N (2022) Satisfactory clinical and radiologic outcomes with a new shorter and modular stem for end-stage hip osteoarthritis: an international prospective multicentre pilot study. SICOT J 8:9. https://doi.org/10.1051/sicotj/2022005
Mori Y, Izumiyama T, Kurishima H, Kamimura M, Baba K, Mori N, Itoi E (2021) Effect of denosumab switched from bisphosphonates in preventing joint destruction in postmenopausal rheumatoid arthritis patients with anti-cyclic citrullinated peptide antibodies. J Orthop Surg Res 16:107. https://doi.org/10.1186/s13018-021-02271-2
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Mori, Y., Mori, N. Approaches to reduce periprosthetic bone resorption after total hip arthroplasty. J Bone Miner Metab 41, 575–576 (2023). https://doi.org/10.1007/s00774-023-01423-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-023-01423-0